Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Aug;5(8):469-79.
doi: 10.1038/nrneph.2009.101. Epub 2009 Jul 7.

Controversies in the treatment of idiopathic membranous nephropathy

Meryl Waldman  1 , Howard A Austin 3rd
Affiliations
Review

Controversies in the treatment of idiopathic membranous nephropathy

Meryl Waldman et al. Nat Rev Nephrol. 2009 Aug.

Abstract

Optimum treatment of idiopathic membranous nephropathy is both controversial and challenging. The most extensively studied and frequently used immunosuppressive regimens for this disease comprise alkylating agents plus corticosteroids or ciclosporin. All of these treatment options have inherent problems: they are not effective in all patients, partial-rather than complete-remissions are common, adverse effects are worrisome, and relapses after treatment cessation remain problematic. Alternative immunosuppressive agents have been tested in an effort to overcome these unresolved issues. This paper reviews the available evidence regarding both established and new agents for the treatment of patients with idiopathic membranous nephropathy, with an emphasis on the results of the most recent clinical trials.

PubMed Disclaimer

References

    1. Schena FP. Survey of the Italian Registry of Renal Biopsies. Frequency of the renal diseases for 7 consecutive years. The Italian Group of Renal Immunopathology. Nephrol. Dial. Transplant. 1997;12:418–426. - PubMed
    1. Haas M, Meehan SM, Karrison TG, Spargo BH. Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976–1979 and 1995–1997. Am. J. Kidney Dis. 1997;30:621–631. - PubMed
    1. Glassock RJ. Secondary membranous glomerulonephritis. Nephrol. Dial. Transplant. 1992;7(Suppl. 1):64–71. - PubMed
    1. Cattran D. Management of membranous nephropathy: when and what for treatment. J. Am. Soc. Nephrol. 2005;16:1188–1194. - PubMed
    1. Passerini P, Ponticelli C. Corticosteroids, cyclophosphamide, and chlorambucil therapy of membranous nephropathy. Semin. Nephrol. 2003;23:355–361. - PubMed

Publication types

Substances